Shared on09 Oct 25Fair value Increased 13%
Analysts have raised their price target for Tilray Brands from $1.50 to $2.00, citing anticipated progress in U.S. cannabis policy and Tilray's strong positioning to benefit from broader market access. Analyst Commentary Recent commentary from bullish analysts highlights both the strengths and potential hurdles facing Tilray Brands in the evolving cannabis market.
Shared on26 Aug 25Fair value Increased 5.99%
Tilray Brands’ consensus price target has increased to $0.983 as analysts cite improved U.S. political momentum toward cannabis rescheduling and Tilray’s strong positioning to benefit from expanding market opportunities. Analyst Commentary Positive political developments, with momentum towards rescheduling marijuana from Schedule I to Schedule III in the U.S., indicating a potential shift in federal cannabis policy.
Shared on01 Aug 25Fair value Decreased 11%
A slight downward revision in revenue growth forecasts has led analysts to lower Tilray Brands’ consensus price target from $1.04 to $0.939. What's in the News Tilray Brands announced a significant impairment of intangible assets and goodwill totaling $1.4 billion in Q4 2025, indicating ongoing financial challenges (Key Developments).